Laverock Therapeutics is expanding its therapeutic pipeline into in vivo [...]

Andelyn Biosciences is manufacturing Ultragenyx’s newly FDA-approved Fayuvi gene therapy [...]

Cyllene Therapeutics’ experimental gene therapy EG110A has received US FDA [...]

Circio has raised approximately NOK 200M (€18.6M) to advance its [...]

Circio and Full Circles Therapeutics are combining circular RNA and [...]

Lumen Bioscience has received up to $7m in US government [...]

Genespire has started enrolling children with severe methylmalonic acidemia in [...]

Andelyn Biosciences and Queen’s University have partnered to develop and [...]

MaxCyte has launched two sequencing-based assays to identify potential off-target [...]

VectorBuilder and Lir Therapeutics have entered a collaboration to optimise [...]